Mehta Kishan insider trades
Mehta Kishan has filed 14 Form 4s with the SEC that we hold, for Biohaven Ltd. (BHVN) (Director), BHVN (Director), Benitec Biopharma Inc. (BNTC) (Director) and DNAA (President, Director, 10% owner), among 6 companies in all. None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2021-07-07 and the latest 2026-04-30.
Biohaven Ltd. (BHVN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
BHVN (BHVN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Benitec Biopharma Inc. (BNTC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
DNAA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
DNAB
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Prokidney Corp. (DNAC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1850520) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms